Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | VU661013 |
Synonyms | |
Therapy Description |
VU661013 is a selective inhibitor of MCL1, which prevents Mcl1 from interacting with Bim, thereby potentially inducing apoptosis and inhibiting cell proliferation (PMID: 30185627, PMID: 31595181). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
VU661013 | MCL1 Inhibitor 18 | VU661013 is a selective inhibitor of MCL1, which prevents Mcl1 from interacting with Bim, thereby potentially inducing apoptosis and inhibiting cell proliferation (PMID: 30185627, PMID: 31595181). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|